Shares of Corteva, Inc. (NYSE:CTVA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-two brokerages that are presently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation and sixteen have issued a buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is $78.2105.
Several brokerages have recently weighed in on CTVA. BNP Paribas Exane raised their target price on Corteva from $70.00 to $72.00 and gave the stock a “neutral” rating in a research report on Monday, November 17th. UBS Group cut their price objective on shares of Corteva from $85.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, October 30th. Royal Bank Of Canada lowered their target price on shares of Corteva from $86.00 to $80.00 and set an “outperform” rating for the company in a report on Friday, October 17th. Argus cut their price target on shares of Corteva from $83.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday, October 13th. Finally, Mizuho cut their target price on Corteva from $85.00 to $78.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 8th.
Get Our Latest Stock Analysis on Corteva
Hedge Funds Weigh In On Corteva
Corteva Price Performance
Shares of CTVA opened at $69.89 on Monday. The firm has a market capitalization of $47.23 billion, a price-to-earnings ratio of 29.87, a PEG ratio of 1.39 and a beta of 0.74. The firm’s fifty day simple moving average is $66.53 and its 200-day simple moving average is $68.68. Corteva has a twelve month low of $53.40 and a twelve month high of $77.41. The company has a current ratio of 1.58, a quick ratio of 1.07 and a debt-to-equity ratio of 0.07.
Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Tuesday, November 4th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.49) by $0.26. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The firm had revenue of $2.62 billion for the quarter, compared to analyst estimates of $2.47 billion. During the same quarter in the prior year, the company posted ($0.49) earnings per share. Corteva’s revenue for the quarter was up 6.5% compared to the same quarter last year. Equities analysts forecast that Corteva will post 2.96 EPS for the current fiscal year.
Corteva Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Monday, December 1st were paid a $0.18 dividend. The ex-dividend date was Monday, December 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. Corteva’s payout ratio is currently 30.77%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
